SARAH ARCEMENT: Open Payments
NPI 1992058507 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,531 in 75 payments from 18 companies in 2025. Trend: 2023 $2,877 · 2024 $3,885 · 2025 $2,531
Food & beverage: $2,531
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $569 |
| Amgen Inc. | 18 | $440 |
| Novartis Pharmaceuticals Corporation | 16 | $346 |
| Abbott Laboratories | 2 | $184 |
| Regeneron Healthcare Solutions, Inc. | 5 | $145 |
| Alnylam Pharmaceuticals Inc. | 1 | $138 |
| Globus Medical, Inc. | 1 | $130 |
| GENZYME CORPORATION | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $112 |
| Lilly USA, LLC | 3 | $66 |
Products named: Ozempic, REPATHA, LEQVIO, CARDIOMEMS, ONPATTRO, Senza, KEVZARA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
